.
MergerLinks Header Logo

New Deal


Announced

Completed

Riverside completed an investment in HealthTech BioActives.

Financials

Edit Data
Transaction Value-
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

Single Bidder

Spain

Private Equity

Pharmaceuticals

Friendly

artificial sweeteners

Acquisition

flavourings

Majority

Completed

Cross Border

Synopsis

Edit

The Riverside Company, a private equity firm completed an investment in HealthTech BioActives, a manufacturer of active pharmaceutical ingredients. Financial terms were not disclosed. “There is incredible potential in the flavor industry for us. We’re excited to help accelerate HTBA’s new product development, driving sales and increasing its existing product portfolio during our hold," Damien Gaudin, Riverside Principal.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US